Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
investing
life sciences
national blog main
new york blog main
startups
23andme
alphabet
american academy of ophthalmology
analytics
antisense oligonucleotide
benzodiazepines
big data
biogen
biomatics capital
blackstone group
blackstone life sciences
boston
boston blog main
boston top stories
boulder/denver blog main
brook byers
clinical trials
columbia university
david goldstein
depression
digisight
drug development
epi4k
epilepsy
essential tremor
ge ventures
glaxosmithkline
gv
health it
kiran reddy
kleiner perkins caufield & byers
lagunita biosciences
major depressive disorder
marcio souza
What
ceo
2
×
drugs
2
×
new
adds
aims
analyzes
backed
cause
company
data
developing
devices
electronic
epilepsy
financing
genes
genetic
gv
health
insights
kapoor
lands
led
links
marcio
medical
medicines
miki
mutations
neuro
praxis
precision
raised
record
research
souza
stop
turn
useful
verana
Language
unset
Current search:
xconomy.com
×
drugs
×
ceo
×
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO
